Financials
- Market Capitalization 1.75 B
- Employee 34
- Founded 2011
- CEO N/A
- Website www.trevitherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG003QGQRB9
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2020 | VIR Vir Biotechnology, Inc. - Common Stock | 10.61 USD | -6.11% | -6.27% | -0.93% | +77.42% | 1.80 B USD | ||
| 2024 | ZYME Zymeworks Inc. - Common Stock | 25.07 USD | -1.03% | -2.64% | -5.93% | +41.32% | 1.78 B USD | ||
| 2034 | XNCR Xencor, Inc. - Common Stock | 23.52 USD | -6.07% | -2.08% | -3.69% | +86.96% | 1.75 B USD | ||
| 2035 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 16.51 USD | -5.33% | -4.46% | -20.66% | -24.13% | 1.74 B USD |